These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8453702

  • 1. A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
    Harstrick A, Bokemeyer C, Schmoll HJ, Köhne-Wömpner CH, Knipp H, Schöffski P, Anagnou J, Wipperman B, Neumann S, Poliwoda H.
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S217-21. PubMed ID: 8453702
    [Abstract] [Full Text] [Related]

  • 2. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
    Toma S, Palumbo R, Canavese G, Albanese E, Cantoni E, Barisone A, Reggiardo G, Rosso R, Santi L.
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
    [Abstract] [Full Text] [Related]

  • 3. Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
    Bokemeyer C, Harstrick A, Schmoll HJ, Köhne-Wömpner CH, Schöffski P, Poliwoda H.
    Ann Oncol; 1992 Jun; 3(6):487-8. PubMed ID: 1498067
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT, Metch B, Weiss SA, Weick JK, Fabian C, Stephens RL, Balcerzak SP.
    Cancer Chemother Pharmacol; 1993 Jun; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [Abstract] [Full Text] [Related]

  • 5. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J, Fra J, López-Pousa A, García del Muro X, Balañá C, Casado A, Martín J, Martínez-Trufero J, de las Peñas R, Buesa JM, Spanish Group for Research on Sarcomas (GEIS).
    Cancer; 2004 Apr 01; 100(7):1498-506. PubMed ID: 15042685
    [Abstract] [Full Text] [Related]

  • 6. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ, Agarwal K, Zornig C, Schwarz R, Dietel M, Hossfeld DK.
    Cancer Chemother Pharmacol; 1993 Apr 01; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology Group.
    Blum RH, Edmonson J, Ryan L, Pelletier L.
    Cancer Chemother Pharmacol; 1993 Apr 01; 31 Suppl 2():S238-40. PubMed ID: 8453706
    [Abstract] [Full Text] [Related]

  • 8. Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.
    Nielsen OS, Reichardt P, Christensen TB, Pink D, Daugaard S, Hermans C, Marreaud S, van Glabbeke M, Blay J, Judson I.
    Eur J Cancer; 2006 Sep 01; 42(14):2303-9. PubMed ID: 16891112
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J, Kellner R, Seeber S.
    Cancer Chemother Pharmacol; 1993 Sep 01; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
    Elias AD, Antman KH.
    Cancer Treat Rep; 1986 Jul 01; 70(7):827-33. PubMed ID: 3087617
    [Abstract] [Full Text] [Related]

  • 12. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH, Wen XP, Hu L.
    Ai Zheng; 2002 Aug 01; 21(8):907-9. PubMed ID: 12478905
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
    Pápai Z, Bodoky G, Szántó J, Poller I, Rahóty P, Eckhardt S, Láng I, Szendroi M.
    Cancer; 2000 Jul 01; 89(1):177-80. PubMed ID: 10897015
    [Abstract] [Full Text] [Related]

  • 14. [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].
    Chen LK, Xu GC, Teng XY, Liang Y, Liu JL, Zhou XM.
    Ai Zheng; 2002 Aug 01; 21(8):903-6. PubMed ID: 12478904
    [Abstract] [Full Text] [Related]

  • 15. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH.
    Ai Zheng; 2007 Dec 01; 26(12):1344-9. PubMed ID: 18076798
    [Abstract] [Full Text] [Related]

  • 16. Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study.
    Siehl JM, Thiel E, Schmittel A, Hütter G, Deckert PM, Szelényi H, Keilholz U.
    Cancer; 2005 Aug 01; 104(3):611-7. PubMed ID: 15968689
    [Abstract] [Full Text] [Related]

  • 17. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY, European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    J Clin Oncol; 2007 Jul 20; 25(21):3144-50. PubMed ID: 17634494
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].
    Becouarn Y, Bui BN, Kerbrat P, Chauvergne J, Brunet R, Robert J.
    Bull Cancer; 1987 Jul 20; 74(2):109-16. PubMed ID: 3475140
    [Abstract] [Full Text] [Related]

  • 19. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R, Dalley D, Bell DR, Levi J, Simes RJ, Wiltshaw E.
    Cancer Chemother Pharmacol; 1993 Jul 20; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [Abstract] [Full Text] [Related]

  • 20. [A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults].
    Jelić S, Tomasević Z, Kreacić M, Kovcin V, Radosavljević D, Vlajić M.
    Bull Cancer; 1996 Dec 20; 83(12):1002-7. PubMed ID: 9116363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.